Categories: BioTechLearnProduct
WE BELIEVE A CURE FOR CANCER IS WITHIN OUR LIFETIME AND WE ARE WORKING WITH URGENCY TO SEE THIS PROMISING POSSIBILITY BECOME A REALITY. Learn More
Investors 5
Mentions in press and media 7
| Date | Title | Description |
| 27.05.2025 | Seneca Therapeutics Announces the Dosing of the First Patient in the SVV-001 Phase I/II Trial | Trial to Demonstrate Safety and Preliminary Efficacy with Poorly Differentiated Neuroendocrine Carcinomas or High-Grade (Grade 3) Neuroendocrine Tumors
PHILADELPHIA, PA, UNITED STATES, May 27, 2025 /EINPresswire.com/ -- Seneca Therapeutics ... |
| 21.03.2023 | VisionTech Angels Invest $190,000 in Seneca Therapeutics Follow-on Round | INDIANAPOLIS, Indiana (March 21, 2023) – – VisionTech Angels, among the Midwest’s most active angel investing networks, has invested $190,000 in Seneca Therapeutics with 16 members participating in the follow-on round. With the investment, ... |
| 05.01.2023 | Monday Moves: 3 Philly biotech companies are starting 2023 with fresh funding | Money Moves is a column where we chart the funding raises of tech companies across the region. Have a tip? Email us at philly@technical.ly. ArriVent Biopharma raises $110 million
Newtown Square-based biopharmaceutical company ArriVent Bioph... |
| 24.02.2022 | Broad Street Angels close 2021 with over $1.68 million in investments | BROAD STREET ANGELS CLOSES 2021 WITH OVER $1.68 million in investments |
| 20.01.2021 | BROAD STREET ANGELS INVESTS IN SENECA THERAPEUTICS WITH BREAKTHROUGH BIOTECHNOLOGY TO TREAT CANCER | FOR IMMEDIATE RELEASE |
| - | Meet June Pitch Presenter #1: Jim Hussey, CEO, Seneca Therapeutics | Life sciences are a sweet spot for VisionTech Angels so when I met Jim Hussey, CEO of Seneca Therapeutics , at the ACA Life Sciences Syndicate meeting and learned about their virus that combats “cold” cancer tumors, I thought our group woul... |
| - | Seneca Therapeutics | “Seneca Therapeutics” |
Reviews 0
